Evaluation of the small-molecule BRD4-degrader CFT-2718 in small cell lung cancer and pancreatic cancer models May 27, 2021 Source Molecular Cancer Therapeutics A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination March 29, 2021 Source Sage Journals High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics January 11, 2021 Source Sage Journals Targeted protein degradation and the enzymology of degraders June 7, 2018 Source ScienceDirect Presentations CFT7455: A novel, IKZF1/3 Degrader That Demonstrates Potent Tumor Regression in a Spectrum of Non-Hodgkin Lymphoma Xenograft Models Source 16th Annual International Conference on Malignant Lymphoma Preclinical Evaluation of CFT8919 as a Mutant Selective Degrader of EGFR with L858R Activating Mutations for the Treatment of Non-Small Cell Lung Cancer Source Keystone Symposium on Targeted Protein Degradation Lessons Learned in Developing JAK2 Degraders Source Keystone Symposium on Targeted Protein Degradation C4T Presentation at Undruggable Leaders Forum Europe Source Undruggable Leaders Forum Europe CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models Source AACR Annual Meeting 2021 BRD9 Pre-clinical Overview Source North American Protein Degradation Congress, February 2021 Understanding the Nuances of Targeted Protein Degradation Source World Pharma Week, December 2020 Computational Methods for Degrader Ternary Complex Prediction using HDX Data Source Protein Structure Determination in Industry Meeting, November 2020 BRD9 Pre-clinical Overview Source Targeted Protein Degradation Summit, October 2020 Degrader Drug Space Source Ubiquitin-Induced Targeted Protein Degradation Conference, August 2020 Pagination Current page 1 Page 2 Next page next › Last page last »
Evaluation of the small-molecule BRD4-degrader CFT-2718 in small cell lung cancer and pancreatic cancer models May 27, 2021 Source Molecular Cancer Therapeutics
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination March 29, 2021 Source Sage Journals
High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics January 11, 2021 Source Sage Journals
CFT7455: A novel, IKZF1/3 Degrader That Demonstrates Potent Tumor Regression in a Spectrum of Non-Hodgkin Lymphoma Xenograft Models Source 16th Annual International Conference on Malignant Lymphoma
Preclinical Evaluation of CFT8919 as a Mutant Selective Degrader of EGFR with L858R Activating Mutations for the Treatment of Non-Small Cell Lung Cancer Source Keystone Symposium on Targeted Protein Degradation
Lessons Learned in Developing JAK2 Degraders Source Keystone Symposium on Targeted Protein Degradation
CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models Source AACR Annual Meeting 2021
Computational Methods for Degrader Ternary Complex Prediction using HDX Data Source Protein Structure Determination in Industry Meeting, November 2020
